News

As the UK market grapples with the ripple effects of China's sluggish economic recovery, evidenced by a dip in the FTSE 100 and FTSE 250 indices, investors are keenly observing how global trade ...
Amidst a backdrop of muted global market reactions to new U.S. tariffs and mixed economic signals, Asian markets have shown resilience, with Chinese indices rising on hopes for further stimulus ...
Ambassador Extraordinary and Plenipotentiary of the People’s Republic of China to the Republic of Belarus Zhang Wenchuan met with Gomel Oblast Governor Ivan Krupko to discuss strengthening cooperation ...
As global markets navigate a landscape marked by new tariffs and mixed economic signals, the Asian indices have shown resilience, with China's Shanghai Composite Index rising over 1% amid hopes for ...
VOV.VN - Passion fruit, banana, pineapple, and coconut are emerging as fruit categories with strong potential to reach US$1 ...
The AUD/USD is trading 0.95% lower so far today and nearly 1.5% down on the week so far. The risk-sensitive Aussie is suffering from a mix of global trade uncertainty, a rush for safety amid growing ...
In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...
EV Charging Station Market to grow from US$ 22.9B in 2022 to US$ 137.4B by 2030, registering a strong CAGR of 25.3% (2024–2031). In 2024, the U.S. continued to lead the EV Charging Stations Market, ...
In the current global market landscape, characterized by muted responses to new U.S. tariffs and mixed economic signals from major regions such as Europe, Japan, and China, investors are carefully ...
The dollar index (DXY00) on Thursday rose by +0.29% and posted a 3.5-week high. Signs of strength in the US economy may keep the Fed from cutting interest rates and are supportive of the dollar.
This has generated discussion about its effects on the Indian pharma industry. Indian pharma industry experts have provided an overview based on available sources. Vikas Nim, pharma industry ...